Zhongtuo Times Investment

Zhongtuo Times is a Chinese biotechnology and investment group headquartered in Beijing, focusing on the fields of regenerative medicine and cellular life sciences. The company operates a sophisticated platform for the research, development, and clinical application of stem cell and immune cell technologies. Its core services include the operation of a professional cell storage bank and the provision of personalized health management solutions based on cellular therapy. Zhongtuo Times is actively involved in exploring therapeutic applications for anti-aging, immune system modulation, and tissue repair. In addition to its R&D activities, the group functions as an investment entity, fostering innovation and growth within the broader healthcare and biotech ecosystem in China. The company aims to integrate advanced biotechnology with clinical practice to improve human health and longevity.